| RS2090684427 |
RTEL1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2090696292 |
RTEL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2090696366 |
RTEL1
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2090699166 |
RTEL1
|
Health Risk |
Pathogenic |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS2090699833 |
RTEL1
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2090721527 |
ELP2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2090722556 |
RTEL1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2090759946 |
LIG3
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 20 (mngie type), Mitochondrial DNA depletion syndrome 20 (mngie type) |
| RS2090775918 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2090782357 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS2090784195 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2090784564 |
RTEL1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2090784696 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2090785469 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2090788449 |
RTEL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS2090789401 |
RTEL1
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2090792717 |
RTEL1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2090805113 |
RTEL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2090805858 |
RTEL1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2090829910 |
GNAS
|
Health Risk |
Pathogenic |
Pseudohypoparathyroidism type 1B, Pseudohypoparathyroidism type 1B |
| RS2090846146 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2090848106 |
GNAS
|
Health Risk |
Pathogenic |
Pseudohypoparathyroidism type I A, 8 conditions |
| RS2090851576 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2090865014 |
TSC2
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2090865155 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2090871271 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2090875352 |
KCNMA1
|
Health Risk |
Likely pathogenic |
Generalized epilepsy-paroxysmal dyskinesia syndrome, KCNMA1-related disorder |
| RS2090909751 |
DYSF
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Miyoshi muscular dystrophy 1 |
| RS2090929102 |
RTEL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS2090933372 |
RTEL1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2090953993 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2090962038 |
DYSF
|
Health Risk |
Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2090965484 |
RTEL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, autosomal recessive 5 |
| RS2090974560 |
GNAS
|
Health Risk |
Likely pathogenic |
— |
| RS2090976265 |
GNAS
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2090976492 |
GNAS
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2090998416 |
CCNQ
|
Health Risk |
Pathogenic |
— |
| RS2091014318 |
HPS4
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 4, Hermansky-Pudlak syndrome 4 |
| RS2091048308 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2091055139 |
CSF2RA
|
Health Risk |
Pathogenic |
Surfactant metabolism dysfunction, pulmonary |
| RS2091055727 |
TSC2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2091058869 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS2091060104 |
CSF2RA
|
Health Risk |
Pathogenic |
Surfactant metabolism dysfunction, pulmonary |
| RS2091068134 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2091085832 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Tuberous sclerosis syndrome |
| RS2091087487 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2091089201 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2091092273 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS2091100543 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2091103854 |
TSC2
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2091139939 |
DYSF
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Miyoshi muscular dystrophy 1 |
| RS2091142154 |
DYSF
|
Health Risk |
Likely pathogenic |
Distal myopathy with anterior tibial onset, Miyoshi muscular dystrophy 1 |
| RS2091144091 |
DYSF
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Miyoshi muscular dystrophy 1 |
| RS2091147162 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2091153561 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2091196149 |
FCHO1
|
Health Risk |
Pathogenic |
Severe congenital neutropenia, Severe congenital neutropenia |
| RS2091196613 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2091198449 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2091199299 |
TTN
|
Health Risk |
Likely pathogenic |
Primary dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS2091199523 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2091200503 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2091205948 |
DEPDC5
|
Health Risk |
Likely pathogenic |
— |
| RS2091208125 |
ATM
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2091211325 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS2091244384 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Breast and/or ovarian cancer |
| RS2091249987 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2091250180 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2091259890 |
ARFGEF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Periventricular heterotopia with microcephaly, autosomal recessive |
| RS2091262473 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2091262802 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2091262986 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2091270014 |
GNAS
|
Health Risk |
Pathogenic |
— |
| RS2091272733 |
GNAS
|
Health Risk |
Pathogenic |
— |
| RS2091273665 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2091273769 |
GNAS
|
Health Risk |
Conflicting classifications of pathogenicity |
GNAS-related disorder, Albright hereditary osteodystrophy |
| RS2091275452 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2091299213 |
CSF2RA
|
Health Risk |
Pathogenic |
Surfactant metabolism dysfunction, pulmonary |
| RS2091303526 |
GNAS
|
Health Risk |
Pathogenic |
Pseudohypoparathyroidism type I A, Pseudohypoparathyroidism type I A |
| RS2091313766 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2091331588 |
GNAS
|
Health Risk |
Likely pathogenic |
Pseudopseudohypoparathyroidism, Pseudopseudohypoparathyroidism |
| RS2091346076 |
MOCOS
|
Health Risk |
Conflicting classifications of pathogenicity |
Xanthinuria type II, Xanthinuria type II |
| RS2091357682 |
KMT2C
|
Health Risk |
Likely pathogenic |
Kleefstra syndrome 2, Kleefstra syndrome 2 |
| RS2091380655 |
GNAS
|
Health Risk |
Pathogenic |
Pseudohypoparathyroidism, Pseudohypoparathyroidism |
| RS2091390332 |
PKD1
|
Health Risk |
Pathogenic/Likely pathogenic |
PKD1-related disorder, Polycystic kidney disease |
| RS2091391674 |
PKD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Polycystic kidney disease, adult type |
| RS2091395464 |
PKD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Polycystic kidney disease |
| RS2091397048 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, Polycystic kidney disease |
| RS2091400232 |
PKD1
|
Health Risk |
Pathogenic |
— |
| RS2091400717 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2091410164 |
PKD1
|
Health Risk |
Likely pathogenic |
— |
| RS2091411664 |
PKD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Polycystic kidney disease, adult type |
| RS2091413514 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, adult type |
| RS2091431794 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2091435565 |
PKD1
|
Health Risk |
Pathogenic |
— |
| RS2091437670 |
SLC6A8
|
Health Risk |
Likely pathogenic |
Creatine transporter deficiency, Creatine transporter deficiency |
| RS2091437893 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2091438383 |
PKD1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2091440383 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2091440547 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, adult type |
| RS2091442608 |
PKD1
|
Health Risk |
Pathogenic |
— |